Tag | Content |
---|
EnhancerAtlas ID | HS162-05800 |
Organism | Homo sapiens |
Tissue/cell | Plasma_cell_myeloma |
Coordinate | chr2:160746910-160749010 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
NFAT5 | MA0606.1 | chr2:160747102-160747112 | ATTTTCCATT | + | 6.02 | NFATC1 | MA0624.1 | chr2:160747102-160747112 | ATTTTCCATT | + | 6.02 | NFATC3 | MA0625.1 | chr2:160747102-160747112 | ATTTTCCATT | + | 6.02 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_59424 | chr2:160734230-160762132 | Ly3 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I159890 | chr2 | 160747029 | 160750311 |
|
Enhancer Sequence | GATCATAAAG TAAGGACATA ATGTTTTCTA TTACTTAGAA TGCTTAGAAA TACTGCAAGT 60 CAATTTGCAT ACTCTTAGGA TATGCCCAAA GGGAGACTGC CATCACTCAT TTAGACCATA 120 TTTTGATCAC AATAAAATTG GAATCATGAC ACACCAAATG ACTCAGGCTG GTTGAAGCTT 180 CCACTCTTTC TTATTTTCCA TTCTCCTTTT ATCCCTATCA ATTACAATGC TGTGTTTTCG 240 CCCATGTCCC TGACTGCCCT CTGCCTGAGA TATGGGTCTC AGTGTGCACA TGTTGTGAAC 300 ACTGAGCTAA TGGAAAACAA GCTCATTTGA ACATAGTGGC AGATGACAGA GGGTTTGCCC 360 ACAGCCTGCA TAAAAACCAC TGTATGTTTA TGTGTGTGCA CAGACATGCT GCTTAAATGG 420 CCAAGATATT GAGCCCAAGT GACTACCTTA TTTGGGAAAC TATGTCCAAA TTTCTCCTTA 480 ATACTTTAAT AAAGAATATA TGATATGTAA TTCACATTAC ATATGCATTA TATATGTATT 540 TGTGTGTATA TATGTGCATA GAAACATATA TACATATGTG TTTGTAGAGT ATGCATAATT 600 TCAGACAAAG AAACTGCAAG CTGTTTCCTG AATGAGAAAT AAAAATTTCA AAACAACTGG 660 TTCAAAATAT ATTCAGAGCC TCCTGTGTAC TCCCCACAAG AGGGGAAGTC CAATGCAGGC 720 TGTGTCAAGT GCATCCCAGG CTCCAACTGG GGGACTTTCC AAAAGGCCTC CTATAGCCAG 780 TTACATATCA GATGTTATAC TCATGATCCT ATAAGCTGGA AGGGCCTTTA GAGATCATCT 840 TGTCTAATGT CCTTATTTAA CAGACAGGAA CAAAGACCTA GAGGTGACTG TGACAGAGCT 900 ATAATGAGGG CACTGGTCTT GTTGATCCTC TGATGGCACA TCCTGCTGCT TCAGCCATTT 960 TTCTATAGCA TAAATAGCAA CAGAGATTCT GACATTTGAT AAAAACAAAA TAGGGTGGAT 1020 TTGAAAGCAC ATTGTCTAAA GGTTCATTAT TACCACTGAG GCCCTACACT TGTAAATCCA 1080 GAAGCTTCCA GGAGTGGGAT GGCAGTGTGT TTGCTATACA ACATGACCTC CATGATTTAG 1140 CAGCCCTCAG GTTTGAGAAA CTTTCTCTTG CTTCTTCCAT AAAAAGTAAC TCTAGGAAGC 1200 ATATGCATGC ATTAACACCA CTGTATGTGT CACACCCCCA AAGCCCCAGC ACACACACAA 1260 CACCCACAGG AGGCTAAAGG CACCAAGATA CATTCCTGTC AAGGCAGCAA GGTACAGTGG 1320 GGGTAAATAT GTACAGTGGG GAAGGAGGAT AAAGAATCCT TCACTAGTGT CCACAAAAAT 1380 GTGGTCTGAC CCTGACAGGT CATTTCACTG ATCTGGGCCT TCTGCCTCTC ACCTGAGAAA 1440 CAGGGGTTTA CATTGGATTA CCTCTAAGCA AACTTTCACA TCTAAATTTC TGATCCAAAT 1500 GATAAGGAGA GTTAAATGAA GTTGATACCT GGCTGACCAA ACTCTGCTTA TTATCAATTA 1560 TAGCTGAAGA AAATACTGGC TTTTTCTATT TTAGTAGGTA GGTTACAGGT GTTGAGAAGC 1620 CTGGGCCTCT AATTAGATAT GTAATCCTCC AAGTGTGGTT CCCAGACCAG CATTATCAGC 1680 ACTACCTGGA AACTTGCCAA ATTTGGGGGG CCCACCAAAA ATCTACTGAA TCAGAATCTC 1740 TGGGCCCTAG ATATCTGTGT TCTAACAAAC TCTCCATGTG ATTCTGTTGC ACCCTGAAAT 1800 CTTAAGTCTT AACCCAGTAT AATCTCTCCA AGCTCTCCAA GAGCTTCTGC ATTCTGAAGC 1860 TCACATTCCC GAAGGAGGGA TCAGCATTAC TAATACCACC TGGCTAGCTA CTCAATGAGT 1920 CAGCCTAGTG TAGCTGTTTG GGACAAGGAC TTCATAGCCA GACTTCCTGG GTTTGAATTC 1980 TAGTTCTGAT ATTTATTAGC TGTGTGATCT TAGGCAAGTT ACATATCTCC CTTGTGCCTC 2040 ACTGTGATCA TCTGTAAAAT GGGGATAAAG TATGGTACCT TTCAGGGTTG CTGTGAGGAC 2100
|